Market revenue in 2023 | USD 2,676.0 million |
Market revenue in 2030 | USD 8,094.7 million |
Growth rate | 17.1% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 58.72% in 2023. Horizon Databook has segmented the Asia Pacific structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The structural heart devices market in the Asia Pacific region is experiencing significant growth, primarily driven by the increasing prevalence of CVDs and the region's rapidly aging population. This demographic shift has heightened the demand for advanced treatment options, including minimally invasive procedures like TAVR.
TAVR has emerged as a widely adopted treatment strategy for Aortic Stenosis (AS) across many Asian countries due to its effectiveness in addressing the condition while offering reduced risks and shorter recovery times compared to traditional surgical approaches.
Moreover, advancements in medical technology and improvements in healthcare infrastructure have facilitated the widespread adoption of TAVR in the region, contributing to the overall growth of the structural heart devices market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific structural heart devices market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account